APP and amyloidosis: Transcriptomics of neuronal FTase knockout in APP/PS1 mice identified mTORC1 signaling and promotion of non-amyloidogenic processing as the top contributor to the beneficial effects on cognition and amyloid pathology, possibly mediated through a reduction in Ras or Rheb signaling [30].